![]() We previously reported a novel negative prognostic biomarker, keratin 17 (K17), whose overexpression in cancer results in shortened patient survival. Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-related deaths in the United States by 2020, due in part to innate resistance to widely used chemotherapeutic agents and limited knowledge about key molecular factors that drive tumor aggression. ![]() L. F. Escobar-Hoyos, Department of Therapeutic Radiology, School of Medicine, Yale University, Hunter Building 15 York Street, Ste HRT 313B, New Haven, CT 06510, USAĮ-mail: Department of Pathology, Renaissance School of Medicine, Stony Brook University, 101 Nicolls Road, Stony Brook, NY 11794, USAĮ-mail: Search for more papers by this author Kenneth R. L. Scampavia, T. Spicer, The Scripps Research Institute, Florida Campus, 130 Scripps Way, Jupiter, FL 33458, USA Genetic Toxicology and Cytogenetics Research Group, Department of Biology, School of Natural Sciences and Education, Universidad del Cauca, Popayán, Colombia Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA of Pathology, Renaissance School of Medicine, Stony Brook University, NY, USAĭepartment of Therapeutic Radiology, School of Medicine, Yale University, New Haven, CT, USAĭavid M.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |